Guardant Health (GH) FCF Margin (2017 - 2026)
Guardant Health (GH) posted FCF Margin of 20.76% for Q2 2026, up 12.05% sequentially from 23.6% in Q1 2026, and up 765.0% YoY from 2.4% in Q2 2025.
Guardant Health (GH) FCF Margin (2017 - 2026) Analysis & Trends
Guardant Health has reported FCF Margin for 10 years, with the latest figure at 20.76% in Q2 2026.
- Quarterly FCF Margin rose 765.0% year-over-year to 20.76% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 20.35% (up 1244.0% YoY) and the FY2025 annual result came in at 23.73%, up 1347.0% from the prior year.
- FCF Margin grew to 20.76% in Q2 2026 per GH's latest filing, from 23.6% in the prior quarter.
- Over five years, FCF Margin peaked at 17.26% in Q3 2025 and troughed at 123.66% in Q2 2022.
- A 5-year average of 48.8% and a median of 47.36% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2023: FCF Margin plunged 3542 bps in 2022, then soared 5072 bps in 2023.
- Over 5 years, FCF Margin stood at 79.4% in 2022, then surged by 33 bps to 53.4% in 2023, then rose by 23 bps to 41.32% in 2024, then jumped by 53 bps to 19.28% in 2025, then declined by 8 bps to 20.76% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 20.76%, 23.6%, and 19.28% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 20.19% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 26.51% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.24% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.59% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 27.51% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Guardant Health | 21.59 Bn | 20.53 Bn | 219.03 Mn | -20.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.76% |
| Mar 31, 2026 | -23.60% |
| Dec 31, 2025 | -3.56% |
| Sep 30, 2025 | -17.26% |
| Jun 30, 2025 | -28.41% |
| Mar 31, 2025 | -33.00% |
| Dec 31, 2024 | -41.32% |
| Sep 30, 2024 | -28.86% |
| Jun 30, 2024 | -55.90% |
| Mar 31, 2024 | -22.09% |
| Dec 31, 2023 | -43.60% |
| Sep 30, 2023 | -56.05% |
| Jun 30, 2023 | -72.94% |
| Mar 31, 2023 | -64.06% |
| Dec 31, 2022 | -125.54% |
| Sep 30, 2022 | -59.77% |
| Jun 30, 2022 | -97.24% |
| Mar 31, 2022 | -53.40% |
| Dec 31, 2021 | -93.99% |
| Sep 30, 2021 | -79.44% |